AI Multi-Horizon Analysis
1m price flat (-0.16%) with neutral RSI (56) and MACD above signal; volume above average but no decisive direction yet.
1H and 15m show overbought RSI (71-77) after the $495 peak; daily MACD still negative; insider selling at $379-$401 adds downside pressure.
Multi-quarter revenue, margin, and FCF expansion remain intact; cash doubled and debt/equity improved to 0.71. Parabolic run (1,300% 12-mo) needs digestion but fundamentals supportive.
Strong fundamental acceleration (revenue +14.9% QoQ, margins +4.28pp OpM, FCF +128%) offset by heavy insider selling and a sharp post-$495 correction; multi-timeframe price action shows consolidation after a parabolic move.
Detailed AI Fundamental Analysis
Business Snapshot
Broadcom Inc. (AVGO) is a global semiconductor and infrastructure software company, listed as common stock on NASDAQ. The firm designs, develops, and supplies a broad range of analog and digital semiconductor devices, as well as enterprise software solutions. The current market price stands at $383.22, trading in pre-market after a volatile session that saw a high of $495.00 and a low of $289.96. The 1-day gain is +14.80% (open $333.82 → close $383.22). No sector/industry classification is provided in the data.
Financial Trends
Revenue trajectory (4 periods, quarterly except Nov-2025 is annual 10-K):
- Aug-2025: $15.952B
- Nov-2025 (annual): $63.887B
- Feb-2026: $19.311B
- May-2026: $22.187B
Period-over-period (Feb→May 2026): revenue +14.9% (from $19.311B to $22.187B). Versus the most recent four-quarter-ago (Aug-2025 quarterly): +39.1%.
Margins – accelerating expansion:
- Gross margin: 67.10% (Aug-2025) → 67.77% (Nov-2025) → 68.13% (Feb-2026) → 69.48% (May-2026) → +2.38pp from four periods ago.
- Operating margin: 36.90% → 39.89% → 44.34% → 48.62% → +11.72pp over four periods.
- Net margin: 25.95% → 36.20% → 38.06% → 41.96% → +16.01pp improvement.
Free Cash Flow (FCF):
- Aug-2025: $19.448B (quarterly)
- Nov-2025 (annual): $26.914B
- Feb-2026: $8.010B (quarterly)
- May-2026: $18.272B (quarterly)
FCF surged +128% from Feb-2026 to May-2026. The cumulative last two quarters ($26.282B) already nearly match the annual figure from Nov-2025. Operating cash flow in May-2026 was $18.753B, up from $8.260B in Feb-2026.
Balance sheet strength:
- Total assets: $165.6B → $179.2B (+8.2% over four periods).
- Cash & equivalents: $10.718B → $19.628B (nearly doubled).
- Long-term debt: $62.655B (May-2026) vs. $61.984B (Nov-2025); slight increase but debt/equity ratio improved: 0.86 → 0.71 (four periods ago to latest).
- Current ratio: 1.50 → 2.24 – liquidity strengthening.
- Inventory: $2.18B → $4.328B (+99%) – notable buildup.
- Shares outstanding: 4.722B → 4.758B (mild dilution from stock-based compensation/financing).
Financial Health
The latest quarter (May-2026) displays accelerating operational momentum:
- Revenue growth is robust, margins are expanding at an increasing rate (operating margin up 4.28pp in one quarter alone).
- Free cash flow generation is exceptional – $18.272B in a single quarter, far exceeding the prior quarter and annual run-rate.
- The balance sheet is fortress-like: cash surged to $19.6B, current ratio above 2.0, and debt/equity declining despite the debt increase.
Key watchpoint: Inventory more than doubled (from $2.18B to $4.33B) over four periods – could indicate either supply chain pre-positioning or potential overstock risk. Retained earnings also fluctuate sharply (from $4.04B to $12.17B), reflecting dividend payouts and share repurchases.
Overall, the company’s fundamentals are in a strong uptrend with improving efficiency and massive cash generation. The only caution is the inventory build, which bears monitoring in subsequent filings.
Insider Activity
Sentiment: Neutral (-10) over the period 2026-04-29 to 2026-07-28.
- Total buys: $373,570 across 4 transactions.
- Total sells: $283,696,980 across 58 transactions.
- Net selling pressure: $283,323,410 (Buys minus Sells).
Notable transactions (last month):
- Mark David Brazeal sold 25,000 shares three times:
- 2026/07/10: $10,033,225 @ $401.33
- 2026/07/08: $9,479,700 @ $379.19
- 2026/06/25: $9,675,000 @ $387.00
- Gayla J. Delly sold 2,390 shares combined (~$728k).
- Justine Page sold 1,602 shares (~$599k).
Insiders are overwhelmingly selling at current elevated prices, but the total insider selling is large relative to typical retail flows. The lack of major buying reinforcement suggests management may view the recent price strength as an opportunity to monetize.
Multi-Timeframe Technical Context
| Timeframe | Price Change (bars) | RSI(14) | MACD Status | Volume vs. 20SMA | Key Levels |
|---|---|---|---|---|---|
| 1m | -0.16% (last 200 bars) | 56.07 | Bullish (MACD > signal) | Above average | Range: 387.04–390.75 |
| 15m | +6.51% (192 bars) | 71.81 – overbought | Bearish (MACD < signal) | Well below average | Range: 360.64–395.09 |
| 1H | -4.48% (200 bars) | 77.49 – overbought | Bullish (MACD > signal) | Below average | Range: 356.43–414.64 |
| 1D | +14.80% (200 bars) | 55.05 – neutral | MACD=-1.84, signal=-3.10 (bearish but converging) | Below 20-day avg | BB: 359.79–404.83; SMA50=398.68, SMA200=365.16 |
| 1W | +368.83% (145 bars) | 60.9 – neutral | Bullish (MACD>signal) but signal above MACD? | Below 20-week avg | BB wide: 283.81–469.13 |
| 1mo | +1296.81% (82 bars) | 65.55 – neutral | Bullish (MACD>signal) | Below 20-month avg | BB: 147.81–468.28 |
Summary: The stock has had a massive multi-year/decade run but is now consolidating after a sharp intraday selloff from the session high of $495. On the daily, it closed well off the high and sits near the middle of the Bollinger Bands. Shorter timeframes (15m, 1H) show recent overbought RSI readings (71–77), suggesting a potential pullback or consolidation. Volume is below moving averages across most timeframes, indicating decreasing participation. The 1D MACD is still negative but closing in on a cross above signal – a potential bullish flip.
Bull / Bear Cases
Short-Term (Hours to Days)
Bull: Price rebounded strongly from the session low ($289.96) and closed near $383. Daily RSI is neutral (55), leaving room for upside. If the 1D MACD crosses above signal (currently close), it could trigger a short-term squeeze back toward the $400–$415 area (1H high, 1D upper BB). Strong earnings trajectory supports valuation.
Bear: The stock is still far below the session high ($495) and the last 1D bar shows a 14.8% gain but with below-average volume. Overbought readings on 15m and 1H RSI (71–77) suggest exhaustion. Insider selling at high levels ($400+) could presage a retest of $360-$370 (1H lows, 1D lower BB). If the daily MACD fails to cross bullish, downside to $350-$330 is possible.
Long-Term (Weeks to Months)
Bull: Fundamental acceleration – revenue, margins, and FCF are all trending strongly higher. With cash generation of ~$18B per quarter, the company has firepower for M&A, buybacks, and dividends. The debt/equity ratio is declining, and liquidity is excellent. If the inventory buildup is a precursor to higher demand, the top-line could continue to surprise.
Bear: The stock is up nearly 1300% over 12 months (monthly timeframe). The recent session high of $495 may have marked a psychological ceiling. Insider selling is massive and consistent. Inventory doubling in four periods could lead to write-downs if demand softens. Any macro slowdown or sector rotation out of semiconductors could compress the multiple. The current price (~$383) is below the 50-day SMA ($398.68), suggesting medium-term weakness.
Key Levels & Triggers
| Level / Trigger | Value | Context |
|---|---|---|
| Immediate resistance | $401.28 | 1H upper Bollinger Band, also near 1D SMA20 ($382.31 is below, but 1H upper at 401.28) |
| Key resistance (short-term) | $414.64 | 1H high from last 200 bars (session high was $495, but that may be an outlier) |
| Major resistance (medium-term) | $468–$469 | 1W and 1mo upper Bollinger Bands – a common upside target if momentum resumes |
| Immediate support | $379.34 | 1H SMA20 and 1D SMA20 ($382.31) – the $380 zone |
| Key support (short-term) | $356.43 | 1H low from 200 bars – could be visited on a retreat |
| Major support (medium-term) | $289.96 | Session low – a break below would signal a deeper correction |
| MACD daily cross | Signal line at -3.10, MACD at -1.84 | A bullish cross (MACD > signal) would likely lift price; a failure to cross keeps bearish pressure |
| Insider sentiment | NWC -$283M | Heavy selling serves as a warning; any higher insider selling (especially Brazeal) at $400+ would reinforce downside risk |
| Earnings date | Not provided | The next 10-Q filing (likely Aug-2026) will reveal if the revenue/margin acceleration continues or if inventory becomes an issue |
